EP 3193936 B1 20200617 - POTENTIATED ANTIMICROBIAL AGENTS
Title (en)
POTENTIATED ANTIMICROBIAL AGENTS
Title (de)
POTENZIERTE ANTIMIKROBIELLE MITTEL
Title (fr)
ANTIMICROBIENS POTENTIALISES
Publication
Application
Priority
- FR 1458663 A 20140915
- FR 1462136 A 20141209
- EP 2015071093 W 20150915
Abstract (en)
[origin: WO2016041958A1] The invention relates to a potentiated antimicrobial agent for use in the treatment of a microbial infection, characterised in that said antimicrobial agent is used in association with a compound of formula I, (I) the mass ratio of compound of formula (I) : antimicrobial agent varying between 8 : 1 and 1 : 10, and in that the microbial infection is induced in particular by a pathogen of strain A and, on said strain A, the concentration of compound (I) corresponds to the following equation: [C] < [CMI] / x, wherein: [C] is the concentration according to the invention of compound (I) to be used on strain A; [CMI] is the CMI measured for compound (I), alone, on strain A; and x is greater than or equal to 100, advantageously greater than 1,000, more advantageously x is between 2,000 and 10,000, or even greater than 50,000.
IPC 8 full level
A61K 45/06 (2006.01); A61K 9/00 (2006.01); A61K 31/09 (2006.01); A61K 31/351 (2006.01); A61K 31/4178 (2006.01); A61K 31/424 (2006.01); A61K 31/43 (2006.01); A61P 31/04 (2006.01); A61P 31/10 (2006.01)
CPC (source: CN EP US)
A61K 9/0053 (2013.01 - EP US); A61K 31/09 (2013.01 - EP US); A61K 31/34 (2013.01 - EP US); A61K 31/351 (2013.01 - EP US); A61K 31/352 (2013.01 - CN EP US); A61K 31/4178 (2013.01 - CN EP US); A61K 31/424 (2013.01 - CN EP US); A61K 31/43 (2013.01 - CN EP US); A61K 31/496 (2013.01 - EP US); A61K 31/65 (2013.01 - EP US); A61K 31/7036 (2013.01 - EP US); A61K 45/06 (2013.01 - CN EP US); A61P 31/04 (2017.12 - EP); A61P 31/10 (2017.12 - EP); Y02A 50/30 (2017.12 - EP US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
FR 3025719 A1 20160318; BR 112017005089 A2 20180123; BR 112017005089 B1 20230110; CN 107073124 A 20170818; CN 107073124 B 20201013; DK 3193936 T3 20200921; EP 3193936 A1 20170726; EP 3193936 B1 20200617; FR 3025720 A1 20160318; FR 3025720 B1 20181109; US 10668043 B2 20200602; US 2018021296 A1 20180125; WO 2016041958 A1 20160324
DOCDB simple family (application)
FR 1458663 A 20140915; BR 112017005089 A 20150915; CN 201580055896 A 20150915; DK 15766125 T 20150915; EP 15766125 A 20150915; EP 2015071093 W 20150915; FR 1462136 A 20141209; US 201515510988 A 20150915